Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Phys Chem Chem Phys ; 24(39): 24487-24494, 2022 Oct 12.
Article in English | MEDLINE | ID: mdl-36193701

ABSTRACT

In this paper, we address the unique nature of fully textured, high surface-to-volume 3C-SiC films, as produced by intrinsic growth anisotropy, in turn generated by the high velocity of the stacking fault growth front in two-dimensional (111) platelets. Structural interpretation of high resolution scanning electron microscopy and transmission electron microscopy data is carried out for samples grown in a hot-wall low-pressure chemical vapour deposition reactor with trichlorosilane and ethylene precursors, under suitable deposition conditions. By correlating the morphology and the X-ray diffraction analysis we also point out that twinning along (111) planes is very frequent in such materials, which changes the free-platelet configuration.

2.
Neuroscience ; 144(4): 1293-304, 2007 Feb 23.
Article in English | MEDLINE | ID: mdl-17187935

ABSTRACT

One important complication of diabetes is damage to the peripheral nervous system. However, in spite of the number of studies on human and experimental diabetic neuropathy, the current therapeutic arsenal is meagre. Consequently, the search for substances to protect the nervous system from the degenerative effects of diabetes has high priority in biomedical research. Neuroactive steroids might be interesting since they have been recently identified as promising neuroprotective agents in several models of neurodegeneration. We have assessed whether chronic treatment with progesterone (P), dihydroprogesterone (DHP) or tetrahydroprogesterone (THP) had neuroprotective effects against streptozotocin (STZ)-induced diabetic neuropathy at the neurophysiological, functional, biochemical and neuropathological levels. Using gas chromatography coupled to mass-spectrometry, we found that three months of diabetes markedly lowered P plasma levels in male rats, and chronic treatment with P restored them, with protective effects on peripheral nerves. In the model of STZ-induced of diabetic neuropathy, chronic treatment for 1 month with P, or with its derivatives, DHP and THP, counteracted the impairment of nerve conduction velocity (NCV) and thermal threshold, restored skin innervation density, and improved Na(+),K(+)-ATPase activity and mRNA levels of myelin proteins, such as glycoprotein zero and peripheral myelin protein 22, suggesting that these neuroactive steroids, might be useful protective agents in diabetic neuropathy. Interestingly, different receptors seem to be involved in these effects. Thus, while the expression of myelin proteins and Na(+),K(+)-ATPase activity are only stimulated by P and DHP (i.e. two neuroactive steroids interacting with P receptor, PR), NCV, thermal nociceptive threshold and intra-epidermal nerve fiber (IENF) density are also affected by THP, which interacts with GABA-A receptor. Because, a therapeutic approach with specific synthetic receptor ligands could avoid the typical side effects of steroids, future experiments will be devoted to evaluating the role of PR and GABA-A receptor in these protective effects.


Subject(s)
Diabetic Neuropathies/drug therapy , Neuroprotective Agents/pharmacology , Peripheral Nerves/drug effects , Peripheral Nerves/metabolism , Progesterone/pharmacology , 20-alpha-Dihydroprogesterone/pharmacology , 20-alpha-Dihydroprogesterone/therapeutic use , Animals , Diabetes Mellitus, Experimental/complications , Diabetic Neuropathies/physiopathology , Diabetic Neuropathies/prevention & control , Down-Regulation/drug effects , Down-Regulation/physiology , Male , Myelin Proteins/genetics , Neural Conduction/drug effects , Neural Conduction/physiology , Neuroprotective Agents/therapeutic use , Pain Threshold/drug effects , Pain Threshold/physiology , Peripheral Nerves/physiopathology , Pregnanolone/pharmacology , Pregnanolone/therapeutic use , Progesterone/blood , Progesterone/therapeutic use , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/drug effects , Receptors, GABA-A/metabolism , Recovery of Function/drug effects , Recovery of Function/physiology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , Skin/innervation , Sodium-Potassium-Exchanging ATPase/metabolism , Treatment Outcome
3.
J Clin Endocrinol Metab ; 86(2): 608-12, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11158017

ABSTRACT

The psychological symptoms assessed with a validated psychometric scale, SCL-90, were significantly higher in postmenopausal women (PMW; 60 subjects) than in premenopausal women (20 subjects). In the same PMW, the activity of the dopaminergic system, assessed with the PRL response to the dopamine-blocking agent sulpiride, was significantly lower than that in premenopausal women. During a period of 12 weeks the 60 PMW were randomly divided into 3 groups: no treatment (group A; n = 20), treatment with estradiol (E(2)) alone (patches with a E(2) release of 50 microg/24 h; group B; n = 20), and treatment with hormonal replacement therapy [estradiol valerate (EV) at a daily dose of 2 mg for 11 days and EV at the same daily doses plus cyproterone acetate (CPA) at a daily dose of 1 mg/day for 10 days; group C; n = 20). At the 12th week of the observation, only in group C women were the psychological symptoms significantly decreased, and the indirect evaluation of the dopaminergic system activity through PRL response to sulpiride showed a significant increase. During the same period, no changes in testosterone levels were observed in any group of PMW, whereas a significant increase in E(2) levels was found in both groups B and C. Although it is likely that the improvement in psychological symptoms with EV and CPA was due to progestin, we cannot rule out the possibility that greater estrogen exposure may have played a role.


Subject(s)
Androgen Antagonists/therapeutic use , Cyproterone Acetate/therapeutic use , Dopamine/physiology , Estradiol/analogs & derivatives , Estrogen Replacement Therapy , Mental Disorders/drug therapy , Postmenopause/psychology , Adult , Anxiety , Area Under Curve , Depression , Estradiol/administration & dosage , Female , Humans , Mental Disorders/etiology , Middle Aged , Postmenopause/physiology , Premenopause/physiology , Premenopause/psychology , Prolactin/blood , Prolactin/metabolism , Psychological Tests , Psychometrics , Reproducibility of Results , Sulpiride
4.
Sleep ; 5(3): 239-47, 1982.
Article in English | MEDLINE | ID: mdl-7134730

ABSTRACT

A prospective epidemiological investigation of excessive daytime sleepiness (EDS) was carried out in an unselected inpatient population admitted to a general hospital during a 1-year period. The study comprised 2518 patients, 1347 female and 1171 male, aged 6-92 years (mean, 55.2). On the basis of histories and clinical and polysomnographic data, EDS was found in 28 cases (1.11%). Of these, 25 (0.99%; 18 female and 7 male; mean age, 61.3) had sleep apnea syndromes (SAS) with predominantly obstructive apnea. Two patients (0.07%; one female and one male; mean age, 65.5) had idiopathic CNS hypersomnia, and one male patient (0.03%) aged 48 years had a combination of narcolepsy and SAS. Differences and agreements of our findings with previous literature data are discussed. The present study shows that in an unselected inpatient population, EDS is a relatively common sleep disorder, usually found in mild to moderate forms. Because it is not severe, it disturbs only relatively domestic activities of elderly retired patients or others who do not work outside the home, and is often masked by other troubles. For these reasons, EDS in the aging population may pass unnoticed in epidemiological studies based only on data from sleep disorder centers.


Subject(s)
Disorders of Excessive Somnolence/epidemiology , Narcolepsy/epidemiology , Sleep Apnea Syndromes/epidemiology , Sleep Wake Disorders/epidemiology , Adolescent , Adult , Aged , Child , Electroencephalography , Female , Humans , Inpatients , Italy , Male , Middle Aged , Prospective Studies , Sex Factors
5.
Arch Dermatol ; 125(11): 1540-2, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2554818

ABSTRACT

The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.


Subject(s)
Antiprotozoal Agents/therapeutic use , Ketoconazole/analogs & derivatives , Leishmaniasis/drug therapy , Adult , Follow-Up Studies , Humans , Itraconazole , Ketoconazole/therapeutic use , Male
6.
Int Clin Psychopharmacol ; 3(3): 245-53, 1988 Jul.
Article in English | MEDLINE | ID: mdl-3153712

ABSTRACT

Unlike conventional antidepressants, rolipram stimulates both the presynaptic as well as the postsynaptic component of monoaminergic transmission. Several double-blind comparative trials are on the way to assess the clinical efficacy and safety of this novel compound. The present study was a randomized double-blind double-dummy comparison with imipramine in inpatients with major, "minor" and atypical depressions (DSM III). Results show no relevant differences between rolipram and imipramine regarding efficacy and safety.


Subject(s)
Antidepressive Agents , Depressive Disorder/drug therapy , Hospitalization , Imipramine/therapeutic use , Pyrrolidinones/therapeutic use , Adolescent , Adult , Aged , Depressive Disorder/psychology , Double-Blind Method , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Rolipram
7.
G Ital Dermatol Venereol ; 125(6): 271-3, 1990 Jun.
Article in Italian | MEDLINE | ID: mdl-2279755

ABSTRACT

A case of a 49-year-old woman affected by wide ulcerations on the face which have been caused by the patient herself, as she has admitted, is reported. The lesions were strictly limited to the area of innervation of the first and second branch of the trigeminal nerve. The patient presented parasthesias and analgesia in the trigeminal area as the consequence of a neurosurgical operation. She also suffered from important psychosis. All these elements enable us to diagnose "trigeminal trophic ulcers". The pathogenesis of this syndrome is discussed.


Subject(s)
Facial Dermatoses/etiology , Skin Ulcer/etiology , Trigeminal Nerve , Cranial Nerve Diseases/etiology , Female , Humans , Middle Aged , Self Mutilation
8.
G Ital Dermatol Venereol ; 124(6): 277-9, 1989 Jun.
Article in Italian | MEDLINE | ID: mdl-2698380

ABSTRACT

Three cases with coexisting psoriasis and bullous pemphigoid are reported and the possible etiopathogenetic relationships between the two diseases are discussed.


Subject(s)
Pemphigoid, Bullous/complications , Psoriasis/complications , Skin Diseases, Vesiculobullous/complications , Aged , Humans , Male , Middle Aged , Pemphigoid, Bullous/etiology
9.
G Ital Dermatol Venereol ; 125(9): 397-9, 1990 Sep.
Article in Italian | MEDLINE | ID: mdl-1706683

ABSTRACT

A case of cutaneous angiogenesis, probably induced by tumour angiogenic factors (TAF), is described. The patient, a 39-year-old female, affected by a vulvar squamous cell carcinoma, developed some erythematoangiomatous lesions on the lower abdominal quadrants, contiguously to the tumour. Histopathologically, the lesions were characterized by vascular neoformation in the superficial dermis and a slight lymphohistiocytic lesions resolved after the polychemotherapy which preceded enlarged vulvectomy. This supports the hypothesis of a close correlation between neoangiogenesis and TAF.


Subject(s)
Carcinoma, Squamous Cell/complications , Neovascularization, Pathologic , Skin/blood supply , Vulvar Neoplasms/complications , Adult , Female , Humans
10.
G Ital Dermatol Venereol ; 124(4): 163-5, 1989 Apr.
Article in Italian | MEDLINE | ID: mdl-2807395

ABSTRACT

The Authors describe the case of a 23 year old woman affected by lichen aureus in a zosteriform pattern localized at the right side of the trunk.


Subject(s)
Skin Diseases , Adult , Chronic Disease , Diagnosis, Differential , Female , Humans , Purpura/diagnosis , Skin/pathology , Skin Diseases/diagnosis , Skin Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL